Table 3. Efficacy comparison.
HHS: Harris Hip Score, WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index
Study | Pain reduction | Functional improvement |
Villanova-López et al. [11] | Significant at 12 months (P < 0.01) | Significant at 12 months (HHS and WOMAC, P < 0.01) |
Di Sante et al. [12] | Significant at 4 weeks (P < 0.01); No significance at 16 weeks (P > 0.05) | No significant improvement at 4 or 16 weeks (WOMAC, P > 0.05) |
Dallari et al. [13] | Significant at all follow-ups, greatest at 6 months (P < 0.0005) | Significant at 2 and 6 months (WOMAC); Not significant at 12 months (P > 0.05) |
Nouri et al. [14] | Significant at all follow-ups (P < 0.01) | Significant at all follow-ups (WOMAC and Lequesne, P < 0.01) |
Doria et al. [15] | Significant at 6 and 12 months (P < 0.01) | Significant at 6 and 12 months (HHS and WOMAC, P < 0.01) |